To build scope & capacity for clinical research
New evidence based knowledge
Research into effective clinical practice
- About Us
- Contact Us
For free and confidential advice about alcohol and other drugs, call the National Alcohol and Other Drug hotline: 1800 250 015. It will automatically direct you to the Alcohol and Drug Information Service in your state or territory. Click here for more information
An online text-based counselling for people concerned about their own drinking or drug use. The service is equally available to people concerned about a family member, relative or friend. Click here for more information
Dr Elizabeth Knock is a clinical psychologist leading an allied health team of counsellors at St Vincent’s Hospital Sydney, Alcohol and Drug Service Outpatients and Stimulant Treatment Program. She provides assessment and psychological interventions for individuals with problematic methamphetamine use, and is responsible for ongoing service development to ensure that treatment is delivered to a high standard, and that it is flexible and responsive to the presenting needs of clients and a growing knowledge and evidence base in this area.
As a clinical psychologist working in substance use treatment for many years, Liz sees daily the benefits of psychosocial interventions and the obvious positive impact these can have when working with the psychological and physical signs of methamphetamine dependence. She also sees the significant gaps and failings in the treatments available particularly for individuals seeking assistance with problematic methamphetamine use and the fast growing need for innovative treatments for both stimulant users seeking assistance for the first time, and those who have tried treatment many times without success. She is particularly interested in investigating how current evidence based psychosocial interventions can be expanded on and integrated alongside other treatment modalities to increase effectiveness.
Psilocybin-facilitated treatment for methamphetamine dependence: A pilot study (Psi-MA)
The study seeks to examine the safety and feasibility of delivering psilocybin facilitated psychotherapy in an outpatient setting to people with methamphetamine use disorder. This will involve development and implementation of a six session treatment protocol integrating psychotherapy (Motivational Interviewing and Acceptance and Commitment therapy) and a single eight hour psilocybin dosing session, with a small pilot population seeking treatment through the Stimulant Treatment Program.